(Q35609347)

9 August 2017

1 reference

title

Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance (English)

1 reference

9 August 2017

1 reference

Dahan A

1

1 reference

9 August 2017

Altman H

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

European Journal of Clinical Nutrition

9 August 2017

published in

1 reference

9 August 2017

volume

58

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

1-9

1 reference

Grapefruit juice-drug interactions

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Interaction of citrus juices with felodipine and nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of grapefruit juice and smoking on verapamil concentrations in steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

P-glycoprotein and multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Influence of grapefruit juice on cisapride pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of grapefruit juice on the pharmacokinetics of sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Drug-grapefruit juice interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Interaction between grapefruit juice and midazolam in humans*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Determination of sildenafil citrate in plasma by high-performance liquid chromatography and a case for the potential interaction of grapefruit juice with sildenafil citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Dramatic inhibition of amiodarone metabolism induced by grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice substantially increases plasma concentrations of buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of grapefruit juice ingestion--pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Drug interactions with cisapride: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Red wine-cisapride interaction: comparison with grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Interaction between grapefruit juice and diazepam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice activates P-glycoprotein-mediated drug transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice does not enhance the effects of midazolam and triazolam in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Inhibition of P-glycoprotein transport function by grapefruit juice psoralen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Grapefruit juice--felodipine interaction in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Disposition of intravenous and oral cyclosporine after administration with grapefruit juice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

First-pass metabolism of cyclosporin by the gut

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

The interaction effect of grapefruit juice is maximal after the first glass

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Effect of grapefruit juice on cyclosporine pharmacokinetics in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Drug interactions with grapefruit: whose responsibility is it to warn the public?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Comparative electrophysiologic effects of intravenous amiodarone and desethylamiodarone in dogs: evidence for clinically relevant activity of the metabolite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

In vitro inhibition of simvastatin metabolism in rat and human liver by naringenin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Effects of grapefruit juice on the stereoselective disposition of nicardipine in humans: evidence for dominant presystemic elimination at the gut site

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Effect of grapefruit juice on blood cyclosporin concentration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1601736

7 January 2021

Identifiers

DOI

10.1038/SJ.EJCN.1601736

1 reference

release_tcmfufxa7na4tbscvjigtg6y4y

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tcmfufxa7na4tbscvjigtg6y4y

24 November 2022

mapped directly with Wikidata item

1 reference